Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study.
Ben Arush MW, Shafat I, Ben Barak A, Shalom RB, Vlodavsky I, Ilan N.
Ben Arush MW, et al.
Pediatr Hematol Oncol. 2009 Jun;26(4):157-64. doi: 10.1080/08880010902754917.
Pediatr Hematol Oncol. 2009.
PMID: 19437318
According to diagnosis, CAT scan and/or FDG/ PET-CT fusion were performed to assess response to treatment after 2-3 courses of chemotherapy. Two patients received VAMP protocol (1 stage IA, 1 stage IIA), 1 received AV-PC (nonbulky stage IIA), 4 received COPP/ABV (3 …
According to diagnosis, CAT scan and/or FDG/ PET-CT fusion were performed to assess response to treatment after 2-3 courses of chemotherapy. …